The Role of Nutrition in Cancer Patients and Cancer Survivors:@0.350661:0.035749:0.914618:0.035749:0.914618:0.019993:0.350661:0.019993:0.008197:0.011738:0.012508:0.005330:0.011680:0.012604:0.003848:0.012508:0.005330:0.012604:0.006042:0.005330:0.014239:0.011699:0.006523:0.005792:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.003848:0.011738:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.009583:0.011699:0.005792:0.010660:0.003848:0.010660:0.012604:0.005792:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
153:@0.950254:0.038184:0.981863:0.038184:0.981863:0.018587:0.950254:0.018587:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
59.   Rock CL, :@0.084242:0.094740:0.197944:0.094740:0.197944:0.080735:0.084242:0.080735:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010382:0.011203:0.011067:0.008586:0.004832:0.013906:0.007902:0.004738:0.004738
et al:@0.198038:0.094740:0.234898:0.094740:0.234898:0.080735:0.198038:0.080735:0.011118:0.005798:0.004841:0.011682:0.003421
. Nutrition and Physical Activ-:@0.234898:0.094740:0.475147:0.094740:0.475147:0.080735:0.234898:0.080735:0.004738:0.004841:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004825:0.011682:0.010434:0.011716:0.004841:0.010126:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421:0.004841:0.012657:0.011067:0.005798:0.003421:0.009476:0.005679
ity Guidelines for Cancer Survivors. :@0.120589:0.108792:0.404922:0.108792:0.404922:0.094787:0.120589:0.094787:0.003421:0.005798:0.009168:0.003848:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.003848:0.005371:0.011203:0.005148:0.003835:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.003835:0.008518:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.004738:0.004738
Ca Can-:@0.404032:0.108792:0.475169:0.108792:0.475169:0.094787:0.404032:0.094787:0.013906:0.011682:0.003848:0.013906:0.011682:0.010434:0.005679
cer J Clin.:@0.120589:0.122844:0.201561:0.122844:0.201561:0.108839:0.120589:0.108839:0.011067:0.011118:0.005148:0.004738:0.008244:0.004738:0.013906:0.003421:0.003421:0.010434:0.004738
 2012;62:242-274.:@0.201544:0.122844:0.339884:0.122844:0.339884:0.108839:0.201544:0.108839:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
60.   Coa, :@0.084242:0.136897:0.166856:0.136897:0.166856:0.122891:0.084242:0.122891:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.011203:0.011682:0.004738:1.113675
et  al:@0.172997:0.136897:0.215896:0.136897:0.215896:0.122891:0.172997:0.122891:0.011118:0.005798:0.004738:0.006142:0.011682:0.003421
.  Capitalizing on  the  “teach-:@0.215896:0.136897:0.475152:0.136897:0.475152:0.122891:0.215896:0.122891:0.004738:0.004738:0.006146:0.013906:0.011682:0.011665:0.003421:0.005798:0.011682:0.003421:0.003421:0.007269:0.003421:0.010434:0.011511:0.010895:0.011203:0.010434:0.004738:0.006140:0.005798:0.010434:0.011118:0.004738:0.006140:0.008586:0.005798:0.011118:0.011682:0.011067:0.010434:0.005679
able” moment to promote healthy dietary:@0.120589:0.150949:0.475168:0.150949:0.475168:0.136944:0.120589:0.136944:0.011682:0.011665:0.003421:0.011118:0.008279:0.005713:0.016044:0.011203:0.016044:0.011118:0.010434:0.005798:0.005713:0.005798:0.011203:0.005713:0.011665:0.005080:0.011203:0.016044:0.011203:0.005798:0.011118:0.005701:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.009168:0.005713:0.011716:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168
changes among cancer survivors: the per-:@0.120589:0.165001:0.475152:0.165001:0.475152:0.150996:0.120589:0.150996:0.011067:0.010434:0.011682:0.010434:0.011511:0.011118:0.006636:0.005410:0.011682:0.016044:0.011203:0.010434:0.011511:0.005410:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005408:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.004738:0.005412:0.005798:0.010434:0.011118:0.005408:0.011665:0.011118:0.005148:0.005679
spectives of healthcare providers. :@0.120589:0.178913:0.409343:0.178913:0.409343:0.164907:0.120589:0.164907:0.006636:0.011665:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.006636:0.006158:0.011203:0.005371:0.006158:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.011067:0.011682:0.005078:0.011118:0.006158:0.011665:0.005080:0.011203:0.009476:0.003421:0.011716:0.011118:0.005148:0.006636:0.004738:0.004738
Support:@0.410763:0.178913:0.475161:0.178913:0.475161:0.164907:0.410763:0.164907:0.008518:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798
Care Cancer:@0.120589:0.192824:0.230536:0.192824:0.230536:0.178818:0.120589:0.178818:0.013906:0.011682:0.005148:0.011118:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2015;23(3):679-686.:@0.230519:0.192824:0.395696:0.192824:0.395696:0.178818:0.230519:0.178818:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
61.   Koene RJ, :@0.084242:0.206735:0.207507:0.206735:0.207507:0.192730:0.084242:0.192730:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010109:0.011203:0.011118:0.010434:0.011118:0.004834:0.010382:0.008244:0.004738:0.004738
et al:@0.207616:0.206735:0.244476:0.206735:0.244476:0.192730:0.207616:0.192730:0.011118:0.005798:0.004841:0.011682:0.003421
. Shared risk factors in cardi-:@0.244476:0.206735:0.475127:0.206735:0.475127:0.192730:0.244476:0.192730:0.004738:0.004841:0.008518:0.010434:0.011682:0.005078:0.011118:0.011716:0.004841:0.005148:0.003421:0.006636:0.008586:0.004841:0.005371:0.011682:0.011067:0.005798:0.011203:0.005148:0.006636:0.004841:0.003421:0.010434:0.004841:0.011067:0.011682:0.005046:0.011716:0.003421:0.005679
ovascular disease and cancer. :@0.120589:0.220646:0.380504:0.220646:0.380504:0.206641:0.120589:0.206641:0.011203:0.009476:0.011682:0.006636:0.011067:0.010399:0.003421:0.011682:0.005148:0.004772:0.011716:0.003421:0.006636:0.011118:0.011682:0.006636:0.011128:0.004762:0.011682:0.010434:0.011716:0.004762:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.004738
Circulation.:@0.380524:0.220646:0.475163:0.220646:0.475163:0.206641:0.380524:0.206641:0.013906:0.003421:0.005148:0.011067:0.010399:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738
2016;133:1104-1114.:@0.120589:0.234557:0.282619:0.234557:0.282619:0.220552:0.120589:0.220552:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
62.   Masoudkabir  F, :@0.084242:0.248469:0.253141:0.248469:0.253141:0.234463:0.084242:0.234463:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011682:0.006636:0.011203:0.010399:0.011716:0.008586:0.011682:0.011665:0.003421:0.005148:0.004738:0.004274:0.006204:0.004738:0.865104
et  al:@0.257407:0.248469:0.298432:0.248469:0.298432:0.234463:0.257407:0.234463:0.011118:0.005798:0.004738:0.004268:0.011682:0.003421
. Cardiovascular dis-:@0.298432:0.248469:0.475137:0.248469:0.475137:0.234463:0.298432:0.234463:0.004738:0.009014:0.013906:0.011682:0.005046:0.011716:0.003421:0.011203:0.009476:0.011682:0.006636:0.011067:0.010399:0.003421:0.011682:0.005148:0.009014:0.011716:0.003421:0.006636:0.005679
ease and cancer: evidence for shared dis-:@0.120589:0.262380:0.475168:0.262380:0.475168:0.248375:0.120589:0.248375:0.011118:0.011682:0.006636:0.011118:0.004943:0.011682:0.010434:0.011716:0.004943:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004928:0.011118:0.009476:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.004943:0.005371:0.011203:0.005148:0.004929:0.006636:0.010434:0.011682:0.005080:0.011118:0.011716:0.004943:0.011716:0.003421:0.006636:0.005679
ease  pathways and  pharmacologic  pre-:@0.120589:0.276291:0.475154:0.276291:0.475154:0.262286:0.120589:0.262286:0.011118:0.011682:0.006636:0.011118:0.004738:0.004095:0.011665:0.011682:0.005798:0.010434:0.014214:0.011682:0.009168:0.006636:0.008843:0.011682:0.010434:0.011716:0.004738:0.004093:0.011665:0.010434:0.011682:0.005622:0.016044:0.011682:0.011067:0.011203:0.003421:0.011203:0.011511:0.003421:0.011067:0.004738:0.004090:0.011665:0.005080:0.011118:0.005679
vention. :@0.120589:0.290202:0.191949:0.290202:0.191949:0.276197:0.120589:0.276197:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Atherosclerosis:@0.191931:0.290202:0.313578:0.290202:0.313578:0.276197:0.191931:0.276197:0.012657:0.005798:0.010434:0.011118:0.005148:0.011203:0.006636:0.011067:0.003421:0.011118:0.005148:0.011203:0.006636:0.003421:0.006636
. 2017;263:343-351.:@0.313561:0.290202:0.466114:0.290202:0.466114:0.276197:0.313561:0.276197:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
63.   Resnick  MJ, :@0.084225:0.304113:0.224662:0.304113:0.224662:0.290108:0.084225:0.290108:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010382:0.011118:0.006636:0.010434:0.003421:0.011067:0.008586:0.004738:0.004269:0.015719:0.008244:0.004738:0.812645
et  al:@0.228928:0.304113:0.269950:0.304113:0.269950:0.290108:0.228928:0.290108:0.011118:0.005798:0.004738:0.004264:0.011682:0.003421
.  Prostate  Cancer  Survi-:@0.269950:0.304113:0.475127:0.304113:0.475127:0.290108:0.269950:0.290108:0.004738:0.004738:0.004266:0.010126:0.005075:0.011203:0.006636:0.005798:0.011682:0.005798:0.011118:0.004738:0.004264:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004262:0.008518:0.010399:0.005148:0.009476:0.003421:0.005679
vorship Care Guideline: American Soci-:@0.120572:0.318025:0.475145:0.318025:0.475145:0.304019:0.120572:0.304019:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.012161:0.013906:0.011682:0.005080:0.011118:0.012161:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.004738:0.012161:0.012657:0.016044:0.011118:0.005148:0.003421:0.011067:0.011682:0.010434:0.012161:0.008518:0.011203:0.011067:0.003421:0.005679
ety of Clinical  Oncology Clinical  Practice:@0.120572:0.331936:0.475152:0.331936:0.475152:0.317931:0.120572:0.317931:0.011118:0.005798:0.009168:0.007611:0.011203:0.005371:0.007611:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738:0.002886:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.007611:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.004738:0.002886:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118
Guideline Endorsement. :@0.120572:0.345847:0.327911:0.345847:0.327911:0.331842:0.120572:0.331842:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.009082:0.009168:0.010434:0.011716:0.011203:0.005148:0.006636:0.011118:0.016044:0.011118:0.010434:0.005798:0.004738:0.004738
J  Clinical Oncol:@0.332239:0.345847:0.470399:0.345847:0.470399:0.331842:0.332239:0.331842:0.008244:0.004738:0.004336:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.009082:0.014864:0.010434:0.011067:0.011203:0.003421
.:@0.470399:0.345847:0.475137:0.345847:0.475137:0.331842:0.470399:0.331842:0.004738
2015;33(9):1078-1085.:@0.120572:0.359758:0.295225:0.359758:0.295225:0.345753:0.120572:0.345753:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
64.   Chao  P, :@0.084225:0.373669:0.197896:0.373669:0.197896:0.359664:0.084225:0.359664:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.010434:0.011682:0.011203:0.004738:0.007866:0.008019:0.004738:0.004738
et al:@0.205769:0.373669:0.250394:0.373669:0.250394:0.359664:0.205769:0.359664:0.011118:0.005798:0.012606:0.011682:0.003421
. The Malnutrition Univer-:@0.250394:0.373669:0.475145:0.373669:0.475145:0.359664:0.250394:0.359664:0.004738:0.012606:0.007286:0.010434:0.011118:0.012606:0.015719:0.011682:0.003421:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.012606:0.011203:0.010434:0.003421:0.009476:0.011118:0.005148:0.005679
sal Screening  Tool  (MUST)  and  a  nutrition:@0.120572:0.387581:0.475147:0.387581:0.475147:0.373575:0.120572:0.373575:0.006636:0.011682:0.003421:0.008501:0.008518:0.011067:0.005078:0.011118:0.011118:0.010434:0.003421:0.010434:0.011511:0.004738:0.003744:0.006448:0.011203:0.011203:0.003421:0.004738:0.003749:0.006312:0.015719:0.011203:0.008518:0.007286:0.006312:0.004738:0.003749:0.011682:0.010434:0.011716:0.004738:0.003753:0.011682:0.004738:0.003754:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434
education  program  for  high  risk cancer:@0.120572:0.401492:0.475145:0.401492:0.475145:0.387487:0.120572:0.387487:0.011118:0.011716:0.010399:0.011067:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.005975:0.011665:0.005080:0.011203:0.011511:0.005148:0.011682:0.016044:0.004738:0.005971:0.005371:0.011203:0.005148:0.004738:0.005973:0.010434:0.003421:0.011511:0.010434:0.004738:0.005976:0.005148:0.003421:0.006636:0.008586:0.010724:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148
patients: strategies to  improve dietary in-:@0.120572:0.415403:0.475140:0.415403:0.475140:0.401398:0.120572:0.401398:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.008364:0.006636:0.005798:0.005148:0.011682:0.005798:0.011118:0.011511:0.003421:0.011118:0.006636:0.008364:0.005798:0.011203:0.004738:0.003618:0.003421:0.016044:0.011665:0.005083:0.011203:0.009476:0.011118:0.008364:0.011716:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168:0.008364:0.003421:0.010434:0.005679
take  in cancer  patients. :@0.120572:0.429314:0.346873:0.429314:0.346873:0.415309:0.120572:0.415309:0.005798:0.011682:0.008586:0.011118:0.004738:0.008166:0.003421:0.010434:0.012914:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.008162:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738
Bio Medicine:@0.355039:0.429314:0.470408:0.429314:0.470408:0.415309:0.355039:0.415309:0.009818:0.003421:0.011203:0.012914:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118
.:@0.470408:0.429314:0.475145:0.429314:0.475145:0.415309:0.470408:0.415309:0.004738
2015;5(3):30-35.:@0.120572:0.443225:0.247846:0.443225:0.247846:0.429220:0.120572:0.429220:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
FURTHER READING:@0.084242:0.472448:0.249342:0.472448:0.249342:0.456414:0.084242:0.456414:0.009236:0.012315:0.011161:0.008082:0.013085:0.010006:0.011161:0.005388:0.011161:0.010006:0.014239:0.013470:0.005388:0.014239:0.016164
1.:@0.084242:0.488971:0.098456:0.488971:0.098456:0.474965:0.084242:0.474965:0.009476:0.004738
  AICR’s Guidelines for  Cancer Survivors.:@0.120589:0.488971:0.475152:0.488971:0.475152:0.474965:0.120589:0.474965:0.004738:-0.004738:0.012657:0.003866:0.013906:0.010382:0.006004:0.006636:0.013820:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.013820:0.005371:0.011203:0.005148:0.004738:0.009072:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.013820:0.008518:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.004738
Available  online:  http://www.aicr.org/pa-:@0.120589:0.502882:0.475156:0.502882:0.475156:0.488876:0.120589:0.488876:0.011409:0.009476:0.011682:0.003421:0.003421:0.011682:0.011665:0.003421:0.011118:0.004738:0.006561:0.011203:0.010434:0.003421:0.003421:0.010434:0.011118:0.004738:0.004738:0.006542:0.010434:0.005798:0.005798:0.011665:0.004738:0.007475:0.007475:0.014214:0.014214:0.014214:0.004738:0.011682:0.003421:0.011067:0.003891:0.004738:0.011203:0.005148:0.011511:0.007475:0.011665:0.011682:0.005679
tientssurvivors/aicrs-guidelines-for-cancer.:@0.120606:0.516793:0.462738:0.516793:0.462738:0.502788:0.120606:0.502788:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.007475:0.011682:0.003421:0.011067:0.005148:0.006636:0.005679:0.011511:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.005679:0.005371:0.011203:0.005148:0.005679:0.011067:0.011682:0.010434:0.011067:0.011118:0.003893:0.004738
html. Accessed 7 January 2018.:@0.120606:0.530704:0.380883:0.530704:0.380883:0.516699:0.120606:0.516699:0.010434:0.005798:0.016044:0.003421:0.004738:0.004738:0.012657:0.011067:0.011067:0.011118:0.006636:0.006636:0.011118:0.011716:0.004738:0.009476:0.004738:0.008244:0.011682:0.010434:0.010399:0.011682:0.005148:0.009168:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
2. :@0.084259:0.544756:0.103194:0.544756:0.103194:0.530751:0.084259:0.530751:0.009476:0.004721:0.004738
 Arends  J, :@0.120589:0.544756:0.204761:0.544756:0.204761:0.530751:0.120589:0.530751:0.000000:0.012657:0.005073:0.011118:0.010434:0.011716:0.006636:0.004738:0.004079:0.008244:0.004738:0.004738
et  al:@0.208831:0.544756:0.249662:0.544756:0.249662:0.530751:0.208831:0.530751:0.011118:0.005798:0.004738:0.004074:0.011682:0.003421
.  ESPEN  expert  group  rec-:@0.249662:0.544756:0.475149:0.544756:0.475149:0.530751:0.249662:0.530751:0.004738:0.004738:0.004085:0.009168:0.008518:0.010126:0.009168:0.012657:0.004738:0.004076:0.011118:0.008210:0.011665:0.011118:0.005148:0.005798:0.004738:0.004071:0.011511:0.005077:0.011203:0.010399:0.011665:0.004738:0.004076:0.005077:0.011118:0.011067:0.005679
ommendations for action against cancer-:@0.120589:0.558809:0.475152:0.558809:0.475152:0.544804:0.120589:0.544804:0.011203:0.016044:0.016044:0.011118:0.010434:0.011716:0.011682:0.005798:0.003421:0.011203:0.010434:0.006636:0.006534:0.005371:0.011203:0.005148:0.006532:0.011682:0.011067:0.005798:0.003421:0.011203:0.010434:0.006537:0.011682:0.011511:0.011682:0.003421:0.010434:0.006636:0.005798:0.006539:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005679
related malnutrition. :@0.120589:0.572861:0.295787:0.572861:0.295787:0.558856:0.120589:0.558856:0.005078:0.011118:0.003421:0.011682:0.005798:0.011118:0.011716:0.008586:0.016044:0.011682:0.003421:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Clin Nutr. :@0.299620:0.572861:0.382867:0.572861:0.382867:0.558856:0.299620:0.558856:0.013906:0.003421:0.003421:0.010434:0.008586:0.012657:0.010399:0.005798:0.005148:0.004738:0.004738
2017;36(5)::@0.386699:0.572861:0.475128:0.572861:0.475128:0.558856:0.386699:0.558856:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738
1187-1196.:@0.120589:0.586913:0.206812:0.586913:0.206812:0.572908:0.120589:0.572908:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
3.:@0.084242:0.600966:0.098456:0.600966:0.098456:0.586960:0.084242:0.586960:0.009476:0.004738
  Bower  JE,  Lamkin  DM.  Inflammation  and:@0.120589:0.600966:0.475142:0.600966:0.475142:0.586960:0.120589:0.586960:0.004738:-0.004738:0.009818:0.011203:0.014214:0.011118:0.005148:0.004738:0.004635:0.008244:0.009168:0.004738:0.004738:0.004647:0.007902:0.011682:0.016044:0.008586:0.003421:0.010434:0.004738:0.004649:0.012726:0.015719:0.004738:0.004738:0.004647:0.003866:0.010434:0.004148:0.004148:0.011682:0.016044:0.016044:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004646:0.011682:0.010434:0.011716
cancer-related fatigue: mechanisms, con- :@0.120572:0.615018:0.479885:0.615018:0.479885:0.601013:0.120572:0.601013:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005679:0.005071:0.011118:0.003421:0.011682:0.005798:0.011118:0.011716:0.005927:0.005371:0.011682:0.005798:0.003421:0.011511:0.010399:0.011118:0.004738:0.005920:0.016044:0.011118:0.011067:0.010434:0.011682:0.010434:0.003421:0.006636:0.016044:0.006636:0.004738:0.005935:0.011067:0.011203:0.010434:0.005679:0.004738
tributing factors, and treatment implica-:@0.120572:0.629070:0.475128:0.629070:0.475128:0.615065:0.120572:0.615065:0.005798:0.005148:0.003421:0.011665:0.010399:0.005798:0.003421:0.010434:0.011511:0.010553:0.005371:0.011682:0.011067:0.005798:0.011203:0.005148:0.006636:0.004729:0.010553:0.011682:0.010434:0.011716:0.010553:0.005798:0.005077:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005790:0.010553:0.003421:0.016044:0.011665:0.003421:0.003421:0.011067:0.011703:0.005679
tions. :@0.120572:0.643123:0.167541:0.643123:0.167541:0.629117:0.120572:0.629117:0.005798:0.003421:0.011203:0.010434:0.006636:0.004738:0.004738
Brain, Behaviours and Immunity.:@0.178795:0.643123:0.475145:0.643123:0.475145:0.629117:0.178795:0.629117:0.009818:0.005148:0.011682:0.003421:0.010434:0.004738:0.016010:0.009818:0.011118:0.010434:0.011682:0.009476:0.003421:0.011203:0.010399:0.005148:0.006636:0.016010:0.011682:0.010434:0.011716:0.016010:0.003866:0.016044:0.016044:0.010399:0.010434:0.003421:0.005798:0.009168:0.004738
2013;30:S48-S57.:@0.120572:0.657175:0.252259:0.657175:0.252259:0.643170:0.120572:0.643170:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.008518:0.009476:0.009476:0.005679:0.008518:0.009476:0.009476:0.004738
4. :@0.084225:0.671227:0.103194:0.671227:0.103194:0.657222:0.084225:0.657222:0.009476:0.004755:0.004738
 Chan, :@0.120589:0.671227:0.176520:0.671227:0.176520:0.657222:0.120589:0.657222:0.000000:0.013906:0.010434:0.011682:0.010434:0.004738:0.004738
et al:@0.178983:0.671227:0.218204:0.671227:0.218204:0.657222:0.178983:0.657222:0.011118:0.005798:0.007201:0.011682:0.003421
. What should we tell prostate:@0.218204:0.671227:0.475164:0.671227:0.475164:0.657222:0.218204:0.657222:0.004738:0.007201:0.016420:0.010434:0.011682:0.005798:0.007201:0.006636:0.010434:0.011203:0.010399:0.003421:0.011716:0.007201:0.014214:0.011118:0.007201:0.005798:0.011118:0.003421:0.003421:0.007201:0.011665:0.005082:0.011203:0.006636:0.005798:0.011682:0.005798:0.011118
cancer  patients about (secondary) pre-:@0.120589:0.685280:0.475154:0.685280:0.475154:0.671274:0.120589:0.671274:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005858:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.010605:0.011682:0.011665:0.011203:0.010399:0.005798:0.010605:0.006312:0.006636:0.011118:0.011067:0.011203:0.010434:0.011716:0.011682:0.005148:0.009168:0.006312:0.010605:0.011665:0.005080:0.011118:0.005679
vention? :@0.120589:0.699332:0.197319:0.699332:0.197319:0.685327:0.120589:0.685327:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.010109:0.004738
Curr Opin Urol:@0.196618:0.699332:0.310644:0.699332:0.310644:0.685327:0.196618:0.685327:0.013906:0.010399:0.005148:0.005148:0.004028:0.014864:0.011665:0.003421:0.010434:0.004037:0.011203:0.005148:0.011203:0.003421
. 2014;24(3):318-323.:@0.310636:0.699332:0.475135:0.699332:0.475135:0.685327:0.310636:0.685327:0.004738:0.004037:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009500:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
5. :@0.084242:0.713384:0.103194:0.713384:0.103194:0.699379:0.084242:0.699379:0.009476:0.004738:0.338810
 Cho J, :@0.120589:0.713384:0.178877:0.713384:0.178877:0.699379:0.120589:0.699379:0.000000:0.013906:0.010434:0.011203:0.005025:0.008244:0.004738:0.004738
et al:@0.179172:0.713384:0.216220:0.713384:0.216220:0.699379:0.179172:0.699379:0.011118:0.005798:0.005029:0.011682:0.003421
. A review of breast cancer sur-:@0.216220:0.713384:0.475142:0.713384:0.475142:0.699379:0.216220:0.699379:0.004738:0.005029:0.012657:0.005029:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.005029:0.011203:0.005371:0.005029:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.005029:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005029:0.006636:0.010399:0.005148:0.005679
vivorship issues from survivors’ perspectives.:@0.120589:0.727437:0.475151:0.727437:0.475151:0.713431:0.120589:0.713431:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.004498:0.003421:0.006636:0.006636:0.010399:0.011118:0.006636:0.004498:0.005371:0.005077:0.011203:0.016044:0.004490:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.006004:0.004498:0.011665:0.011118:0.005148:0.006636:0.011665:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.006636:0.004738
J Breast Cancer.:@0.120589:0.741489:0.256603:0.741489:0.256603:0.727484:0.120589:0.727484:0.008244:0.004738:0.009818:0.005148:0.011118:0.011682:0.006636:0.005798:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
 2014;17(3):189-199.:@0.256586:0.741489:0.417025:0.741489:0.417025:0.727484:0.256586:0.727484:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
6.:@0.084242:0.755541:0.098456:0.755541:0.098456:0.741536:0.084242:0.741536:0.009476:0.004738
  De Waele E, :@0.120589:0.755541:0.228877:0.755541:0.228877:0.741536:0.120589:0.741536:0.004738:-0.004738:0.012726:0.011118:0.006448:0.015565:0.011682:0.011118:0.003421:0.011118:0.006448:0.009168:0.004738:0.004738
et al:@0.230587:0.755541:0.269055:0.755541:0.269055:0.741536:0.230587:0.741536:0.011118:0.005798:0.006448:0.011682:0.003421
. Nutrition therapy in ca-:@0.269055:0.755541:0.475149:0.755541:0.475149:0.741536:0.269055:0.741536:0.004738:0.006448:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.006435:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.006448:0.003421:0.010434:0.006448:0.011067:0.011682:0.005679
chectic  cancer  patients.  The  Tight  Ca-:@0.120589:0.769452:0.475149:0.769452:0.475149:0.755447:0.120589:0.755447:0.011067:0.010434:0.011118:0.011067:0.005798:0.003421:0.011067:0.004738:0.007204:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.007201:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738:0.007206:0.007286:0.010434:0.011118:0.004738:0.007201:0.007808:0.003421:0.011511:0.010434:0.005798:0.004738:0.007204:0.013906:0.011682:0.005679
loric Control (TiCaCo) pilot trial. :@0.120589:0.783364:0.394524:0.783364:0.394524:0.769358:0.120589:0.769358:0.003421:0.011203:0.005148:0.003421:0.011067:0.007406:0.013906:0.011203:0.010434:0.005798:0.005077:0.011203:0.003421:0.007406:0.006312:0.007812:0.003421:0.013906:0.011682:0.013906:0.011203:0.006312:0.007406:0.011665:0.003421:0.003421:0.011203:0.005798:0.007406:0.005798:0.005148:0.003421:0.011682:0.003421:0.004738:0.004738
Appetite.:@0.397192:0.783364:0.475171:0.783364:0.475171:0.769358:0.397192:0.769358:0.012657:0.011665:0.011665:0.011118:0.005798:0.003421:0.005798:0.011118:0.004738
2015;91:298-301.:@0.120589:0.797275:0.254191:0.797275:0.254191:0.783270:0.120589:0.783270:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
7. :@0.084242:0.811186:0.103194:0.811186:0.103194:0.797181:0.084242:0.797181:0.009476:0.004738:0.004738
 Demark-Wahnefried W, :@0.120589:0.811186:0.317606:0.811186:0.317606:0.797181:0.120589:0.797181:0.000000:0.012726:0.011118:0.016044:0.011682:0.005148:0.008586:0.005679:0.015567:0.011682:0.010434:0.010434:0.011118:0.005371:0.005148:0.003421:0.011118:0.011716:0.005942:0.014607:0.004738:0.004738
et al:@0.318812:0.811186:0.356783:0.811186:0.356783:0.797181:0.318812:0.797181:0.011118:0.005798:0.005952:0.011682:0.003421
. Weight man-:@0.356783:0.811186:0.475154:0.811186:0.475154:0.797181:0.356783:0.797181:0.004738:0.005952:0.015618:0.011118:0.003421:0.011511:0.010434:0.005798:0.005942:0.016044:0.011682:0.010434:0.005679
agement and physical activity throughout:@0.120589:0.825391:0.475164:0.825391:0.475164:0.811386:0.120589:0.811386:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.005853:0.011682:0.010434:0.011716:0.005867:0.011665:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421:0.005867:0.011682:0.011067:0.005798:0.003421:0.009476:0.003421:0.005798:0.009168:0.005867:0.005798:0.010434:0.005078:0.011203:0.010399:0.011511:0.010434:0.011203:0.010399:0.005798
the cancer care continuum. :@0.120589:0.839596:0.359227:0.839596:0.359227:0.825591:0.120589:0.825591:0.005798:0.010434:0.011118:0.004382:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004384:0.011067:0.011682:0.005078:0.011118:0.004387:0.011067:0.011203:0.010434:0.005798:0.003421:0.010434:0.010399:0.010399:0.016044:0.004738:0.004738
Cancer J Clin:@0.358870:0.839596:0.470420:0.839596:0.470420:0.825591:0.358870:0.825591:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004382:0.008244:0.004387:0.013906:0.003421:0.003421:0.010434
.:@0.470420:0.839596:0.475157:0.839596:0.475157:0.825591:0.470420:0.825591:0.004738
2017;22. Doi: 10.3322/caac.21441.:@0.120589:0.853802:0.399903:0.853802:0.399903:0.839796:0.120589:0.839796:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.004738:0.012726:0.011203:0.003421:0.004738:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.007475:0.011067:0.011682:0.011682:0.011067:0.004738:0.009476:0.009476:0.009476:0.009476:0.009476:0.004738
8. :@0.084242:0.868007:0.103194:0.868007:0.103194:0.854001:0.084242:0.854001:0.009476:0.004738:0.113905
 Donovan  MG, :@0.120589:0.868007:0.246645:0.868007:0.246645:0.854001:0.120589:0.854001:0.000000:0.012726:0.011203:0.010434:0.011203:0.009476:0.011682:0.010434:0.004738:0.004050:0.015719:0.014915:0.004738:0.004738
et al:@0.250702:0.868007:0.291513:0.868007:0.291513:0.854001:0.250702:0.854001:0.011118:0.005798:0.008792:0.011682:0.003421
. Mediterranean  diet::@0.291513:0.868007:0.475154:0.868007:0.475154:0.854001:0.291513:0.854001:0.004738:0.008792:0.015719:0.011118:0.011716:0.003421:0.005798:0.011118:0.005148:0.005148:0.011682:0.010434:0.011118:0.011682:0.010434:0.004738:0.004045:0.011716:0.003421:0.011118:0.005798:0.004738
prevention of colorectal cancer. :@0.120589:0.882212:0.398270:0.882212:0.398270:0.868207:0.120589:0.868207:0.011665:0.005080:0.011118:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.005851:0.011203:0.005371:0.005855:0.011067:0.011203:0.003421:0.011203:0.005077:0.011118:0.011067:0.005798:0.011682:0.003421:0.005867:0.011067:0.011682:0.010434:0.011067:0.011118:0.003888:0.004738:0.004738
Clin Nutr:@0.399373:0.882212:0.470425:0.882212:0.470425:0.868207:0.399373:0.868207:0.013906:0.003421:0.003421:0.010434:0.005867:0.012657:0.010399:0.005798:0.005148
.:@0.470408:0.882212:0.475145:0.882212:0.475145:0.868207:0.470408:0.868207:0.004738
2017;4:59. Doi: 10.3389/fnut.2017.00059 .:@0.120589:0.896264:0.448001:0.896264:0.448001:0.882259:0.120589:0.882259:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.004738:0.004738:0.012726:0.011203:0.003421:0.004738:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.007475:0.005371:0.010434:0.010399:0.005798:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
9. :@0.523636:0.094777:0.542588:0.094777:0.542588:0.080771:0.523636:0.080771:0.009476:0.004738:0.004738
  El-Shami K, :@0.559983:0.094777:0.652841:0.094777:0.652841:0.080771:0.559983:0.080771:0.004738:-0.004738:0.009168:0.003421:0.005679:0.008518:0.010434:0.011682:0.016044:0.003421:0.004907:0.010109:0.004738:0.004738
et al:@0.652997:0.094777:0.689911:0.094777:0.689911:0.080771:0.652997:0.080771:0.011118:0.005798:0.004895:0.011682:0.003421
. American Cancer Society:@0.689911:0.094777:0.914544:0.094777:0.914544:0.080771:0.689911:0.080771:0.004738:0.004895:0.012657:0.016044:0.011118:0.005148:0.003421:0.011067:0.011682:0.010434:0.004890:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004892:0.008518:0.011203:0.011067:0.003421:0.011118:0.005798:0.009168
Colorectal cancer survivorship care guide-:@0.559983:0.108653:0.914555:0.108653:0.914555:0.094647:0.559983:0.094647:0.013906:0.011203:0.003421:0.011203:0.005073:0.011118:0.011067:0.005798:0.011682:0.003421:0.005080:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005070:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.005080:0.011067:0.011682:0.005078:0.011118:0.005080:0.011511:0.010399:0.003421:0.011716:0.011118:0.005679
lines. :@0.559983:0.122529:0.604489:0.122529:0.604489:0.108523:0.559983:0.108523:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.004738
Cancer J Clin:@0.604489:0.122529:0.716745:0.122529:0.716745:0.108523:0.604489:0.108523:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.008244:0.004738:0.013906:0.003421:0.003421:0.010434
. 2015;65(6):428-455.:@0.716745:0.122529:0.881921:0.122529:0.881921:0.108523:0.716745:0.108523:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
10.   Gallo M,:@0.523636:0.136404:0.631722:0.136404:0.631722:0.122399:0.523636:0.122399:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.014915:0.011682:0.003421:0.003421:0.011203:0.006640:0.015719:0.649525
 et al:@0.631722:0.136404:0.677015:0.136404:0.677015:0.122399:0.631722:0.122399:0.006636:0.011118:0.005798:0.006636:0.011682:0.003421
. Adverse glycaemic effects:@0.677015:0.136404:0.914556:0.136404:0.914556:0.122399:0.677015:0.122399:0.004738:0.006636:0.012657:0.011716:0.009476:0.011118:0.005148:0.006636:0.011118:0.006636:0.011511:0.003421:0.009168:0.011067:0.011682:0.011118:0.016044:0.003421:0.011067:0.006636:0.011118:0.005419:0.005371:0.011118:0.011067:0.005798:0.006636
of cancer therapy: indications for a ration-:@0.559983:0.150280:0.914550:0.150280:0.914550:0.136275:0.559983:0.136275:0.011203:0.005371:0.005285:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005285:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.004738:0.005285:0.003421:0.010434:0.011716:0.003421:0.011067:0.011682:0.005798:0.003421:0.011203:0.010434:0.006636:0.005296:0.005371:0.011203:0.005148:0.005285:0.011682:0.005285:0.005148:0.011682:0.005798:0.003421:0.011203:0.010434:0.005679
al approach to cancer patients with dia-:@0.559983:0.164156:0.914543:0.164156:0.914543:0.150151:0.559983:0.150151:0.011682:0.003421:0.007423:0.011682:0.011665:0.011665:0.005083:0.011203:0.011682:0.011067:0.010434:0.007423:0.005798:0.011203:0.007423:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.007423:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.007423:0.014214:0.003421:0.005798:0.010434:0.007423:0.011716:0.003421:0.011682:0.005679
betes. :@0.559983:0.178032:0.615795:0.178032:0.615795:0.164027:0.559983:0.164027:0.011665:0.011118:0.005798:0.011118:0.006636:0.004738:0.004738
Metabolism Clinical and Experimen-:@0.616085:0.178032:0.914539:0.178032:0.914539:0.164027:0.616085:0.164027:0.015719:0.011118:0.005798:0.011682:0.011665:0.011203:0.003421:0.003421:0.006636:0.016044:0.005046:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.005046:0.011682:0.010434:0.011716:0.005046:0.009168:0.008210:0.011665:0.011118:0.005148:0.003421:0.016044:0.011118:0.010434:0.005679
tal.:@0.559983:0.191908:0.585623:0.191908:0.585623:0.177903:0.559983:0.177903:0.005798:0.011682:0.003421:0.004738
 2018;78:141-154.:@0.585623:0.191908:0.723963:0.191908:0.723963:0.177903:0.585623:0.177903:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
11.   George SM, :@0.523636:0.205784:0.663134:0.205784:0.663134:0.191779:0.523636:0.191779:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.014915:0.011118:0.011203:0.005148:0.011511:0.011118:0.004425:0.008518:0.015719:0.004738:0.517197
et al:@0.662832:0.205784:0.699281:0.205784:0.699281:0.191779:0.662832:0.191779:0.011118:0.005798:0.004430:0.011682:0.003421
. Better post diagnosis diet:@0.699281:0.205784:0.914548:0.205784:0.914548:0.191779:0.699281:0.191779:0.004738:0.004430:0.009818:0.011118:0.005798:0.005798:0.011118:0.005148:0.004421:0.011665:0.011203:0.006636:0.005798:0.004430:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.004430:0.011716:0.003421:0.011118:0.005798
quality  is associated with reduced risk of:@0.559983:0.219954:0.914536:0.219954:0.914536:0.205949:0.559983:0.205949:0.011665:0.010399:0.011682:0.003421:0.003421:0.005798:0.009168:0.004738:0.003866:0.003421:0.006636:0.008586:0.011682:0.006636:0.006636:0.011203:0.011067:0.003421:0.011682:0.005798:0.011118:0.011716:0.008586:0.014214:0.003421:0.005798:0.010434:0.008586:0.005077:0.011118:0.011716:0.010399:0.011067:0.011118:0.011716:0.008586:0.005148:0.003421:0.006636:0.008586:0.008586:0.011203:0.005371
death  among  postmenopausal  women:@0.559983:0.234124:0.914551:0.234124:0.914551:0.220119:0.559983:0.220119:0.011716:0.011118:0.011682:0.005798:0.010434:0.004738:0.008710:0.011682:0.016044:0.011203:0.010434:0.011511:0.004738:0.008706:0.011665:0.011203:0.006636:0.005798:0.016044:0.011118:0.010434:0.011203:0.011665:0.011682:0.010399:0.006636:0.011682:0.003421:0.004738:0.008715:0.014214:0.011203:0.016044:0.011118:0.010434
with invasive  breast cancer in the Wom-:@0.559983:0.248294:0.914541:0.248294:0.914541:0.234289:0.559983:0.234289:0.014214:0.003421:0.005798:0.010434:0.008792:0.003421:0.010434:0.009476:0.011682:0.006636:0.003421:0.009476:0.011118:0.004738:0.004073:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.008792:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.008792:0.003421:0.010434:0.008792:0.005798:0.010434:0.011118:0.008792:0.015633:0.011203:0.016044:0.005679
en’s Health Initiative. :@0.559983:0.262464:0.750474:0.262464:0.750474:0.248458:0.559983:0.248458:0.011118:0.010434:0.006004:0.006636:0.012127:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.012127:0.003866:0.010434:0.003421:0.005798:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.004738:0.004738
Cancer Epidemiol:@0.757863:0.262464:0.914522:0.262464:0.914522:0.248458:0.757863:0.248458:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.012127:0.009168:0.011665:0.003421:0.011716:0.011118:0.016044:0.003421:0.011203:0.003421
Biomarkers Prev. :@0.559983:0.276634:0.698870:0.276634:0.698870:0.262628:0.559983:0.262628:0.009818:0.003421:0.011203:0.016044:0.011682:0.005148:0.008586:0.011118:0.005148:0.006636:0.004738:0.010126:0.005148:0.011118:0.009476:0.004738:0.004738
2014;23(4);1-9.:@0.698853:0.276634:0.816651:0.276634:0.816651:0.262628:0.698853:0.262628:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.005679:0.009476:0.004738
12.   Hackshaw-McGeagh LE, :@0.523636:0.290804:0.768210:0.290804:0.768210:0.276798:0.523636:0.276798:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.011682:0.011682:0.011067:0.008586:0.006636:0.010434:0.011682:0.014214:0.005679:0.015719:0.011067:0.014915:0.011118:0.011682:0.011511:0.010434:0.003573:0.007902:0.009168:0.004738:0.288457
et al:@0.767048:0.290804:0.802643:0.290804:0.802643:0.276798:0.767048:0.276798:0.011118:0.005798:0.003575:0.011682:0.003421
. A systematic :@0.802643:0.290804:0.919294:0.290804:0.919294:0.276798:0.802643:0.276798:0.004738:0.003575:0.012657:0.003575:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.004738
review of dietary, nutritional, and physical:@0.559983:0.304973:0.914521:0.304973:0.914521:0.290968:0.559983:0.290968:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.006705:0.011203:0.005371:0.006705:0.011716:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168:0.004738:0.006705:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004738:0.006705:0.011682:0.010434:0.011716:0.006705:0.011665:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421
activity interventions for the prevention of:@0.559983:0.319143:0.914551:0.319143:0.914551:0.305138:0.559983:0.305138:0.011682:0.011067:0.005798:0.003421:0.009476:0.003421:0.005798:0.009168:0.006996:0.003421:0.010434:0.005798:0.011118:0.005148:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.006636:0.006975:0.005371:0.011203:0.005148:0.006977:0.005798:0.010434:0.011118:0.006979:0.011665:0.005080:0.011118:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.006979:0.011203:0.005371
prostate cancer progression and mortality.:@0.559983:0.333313:0.914558:0.333313:0.914558:0.319308:0.559983:0.319308:0.011665:0.005080:0.011203:0.006636:0.005798:0.011682:0.005798:0.011118:0.005207:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005203:0.011665:0.005080:0.011203:0.011511:0.005071:0.011118:0.006636:0.006636:0.003421:0.011203:0.010434:0.005217:0.011682:0.010434:0.011716:0.005217:0.016044:0.011203:0.005148:0.005798:0.011682:0.003421:0.003421:0.005798:0.009168:0.004738
Cancer Causes Control:@0.559983:0.347483:0.753096:0.347483:0.753096:0.333478:0.559983:0.333478:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004127:0.013906:0.011682:0.010399:0.006636:0.011118:0.006636:0.004139:0.013906:0.011203:0.010434:0.005798:0.005148:0.011203:0.003421
. 2015;26:1521-1550.:@0.753074:0.347483:0.914515:0.347483:0.914515:0.333478:0.753074:0.333478:0.004738:0.004131:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009495:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
13.   Mayer  DK, :@0.523636:0.361653:0.653433:0.361653:0.653433:0.347648:0.523636:0.347648:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011682:0.009168:0.011118:0.005148:0.004738:0.003566:0.012726:0.010109:0.004738:0.300180
et  al:@0.656999:0.361653:0.697323:0.361653:0.697323:0.347648:0.656999:0.347648:0.011118:0.005798:0.004738:0.003566:0.011682:0.003421
.  Summing  it up:  an inte-:@0.697323:0.361653:0.914556:0.361653:0.914556:0.347648:0.697323:0.347648:0.004738:0.004738:0.003566:0.008518:0.010399:0.016044:0.016044:0.003421:0.010434:0.011511:0.004738:0.003566:0.003421:0.005798:0.008313:0.010399:0.011665:0.004738:0.004738:0.003566:0.011682:0.010434:0.008313:0.003421:0.010434:0.005798:0.011118:0.005679
grative review of studies of cancer survi-:@0.559983:0.375823:0.914538:0.375823:0.914538:0.361818:0.559983:0.361818:0.011511:0.005148:0.011682:0.005798:0.003421:0.009476:0.011118:0.008638:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.008638:0.011203:0.005371:0.008638:0.006636:0.005798:0.010399:0.011716:0.003421:0.011118:0.006636:0.008638:0.011203:0.005371:0.008638:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.008638:0.006636:0.010399:0.005148:0.009476:0.003421:0.005679
vorship  care  plans  (2006-2013). :@0.559983:0.389993:0.839485:0.389993:0.839485:0.375988:0.559983:0.375988:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.004738:0.006970:0.011067:0.011682:0.005080:0.011118:0.004738:0.006967:0.011665:0.003421:0.011682:0.010434:0.006636:0.004738:0.006970:0.006312:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.006312:0.004767:0.004738
Cancer.:@0.846464:0.389993:0.914556:0.389993:0.914556:0.375988:0.846464:0.375988:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
2015;1:121(7):978-996.:@0.559983:0.404163:0.739374:0.404163:0.739374:0.390158:0.559983:0.390158:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
14.   Miller  KD, :@0.523636:0.418333:0.645707:0.418333:0.645707:0.404327:0.523636:0.404327:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.003421:0.003421:0.003421:0.011118:0.005148:0.004738:0.006428:0.010109:0.012726:0.004738:0.225463
et  al:@0.652124:0.418333:0.695303:0.418333:0.695303:0.404327:0.652124:0.404327:0.011118:0.005798:0.004738:0.006421:0.011682:0.003421
.  Cancer  Treatment  and:@0.695303:0.418333:0.914538:0.418333:0.914538:0.404327:0.695303:0.404327:0.004738:0.004738:0.006421:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.006418:0.006773:0.005078:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005798:0.004738:0.006414:0.011682:0.010434:0.011716
Survivorship Statistics, 2016. :@0.559983:0.432503:0.790191:0.432503:0.790191:0.418497:0.559983:0.418497:0.008518:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.007184:0.008518:0.005798:0.011682:0.005798:0.003421:0.006636:0.005798:0.003421:0.011067:0.006636:0.004738:0.007184:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
Cancer J Clin.:@0.792671:0.432503:0.914556:0.432503:0.914556:0.418497:0.792671:0.418497:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.007184:0.008244:0.007184:0.013906:0.003421:0.003421:0.010434:0.004738
2016;66:271-289.:@0.559983:0.446672:0.693585:0.446672:0.693585:0.432667:0.559983:0.432667:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
15.   Pelser C, :@0.523636:0.460842:0.634596:0.460842:0.634596:0.446837:0.523636:0.446837:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.011118:0.003421:0.006636:0.011118:0.005148:0.003664:0.013906:0.004738:0.004738
et al:@0.633532:0.460842:0.669217:0.460842:0.669217:0.446837:0.633532:0.446837:0.011118:0.005798:0.003665:0.011682:0.003421
. Prediagnostic lifestyle factors :@0.669217:0.460842:0.919291:0.460842:0.919291:0.446837:0.669217:0.446837:0.004738:0.003665:0.010126:0.005075:0.011118:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.005798:0.003421:0.011067:0.003669:0.003421:0.003421:0.005371:0.011118:0.006636:0.005798:0.009168:0.003421:0.011118:0.003677:0.005371:0.011682:0.011067:0.005798:0.011203:0.005148:0.006636:0.004738
and survival after colon and rectal cancer:@0.559983:0.474424:0.914565:0.474424:0.914565:0.460419:0.559983:0.460419:0.011682:0.010434:0.011716:0.005354:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011682:0.003421:0.005364:0.011682:0.005371:0.005798:0.011118:0.005148:0.005354:0.011067:0.011203:0.003421:0.011203:0.010434:0.005354:0.011682:0.010434:0.011716:0.005354:0.005078:0.011118:0.011067:0.005798:0.011682:0.003421:0.005354:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148
diagnosis in the National Institutes of Health:@0.559983:0.488006:0.914534:0.488006:0.914534:0.474001:0.559983:0.474001:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.004305:0.003421:0.010434:0.004293:0.005798:0.010434:0.011118:0.004293:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004293:0.003866:0.010434:0.006636:0.005798:0.003421:0.005798:0.010399:0.005798:0.011118:0.006636:0.004293:0.011203:0.005371:0.004293:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434
(NIH)-AARP Diet and Health Study. :@0.559983:0.501588:0.846649:0.501588:0.846649:0.487583:0.559983:0.487583:0.006312:0.012657:0.003866:0.011682:0.006312:0.005679:0.012657:0.012657:0.010382:0.010126:0.004548:0.012726:0.003421:0.011118:0.005798:0.004567:0.011682:0.010434:0.011716:0.004557:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.004558:0.008518:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Cancer:@0.846464:0.501588:0.909819:0.501588:0.909819:0.487583:0.846464:0.487583:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
.:@0.909819:0.501588:0.914556:0.501588:0.914556:0.487583:0.909819:0.487583:0.004738
2014;120:1540-1547.:@0.559983:0.515170:0.722013:0.515170:0.722013:0.501165:0.559983:0.501165:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
16.   Reeves  MM, :@0.523636:0.528752:0.671307:0.528752:0.671307:0.514747:0.523636:0.514747:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010382:0.011118:0.011118:0.009476:0.011118:0.006636:0.004738:0.005824:0.015719:0.015719:0.004738:0.004738
et  al:@0.677131:0.528752:0.719707:0.528752:0.719707:0.514747:0.677131:0.514747:0.011118:0.005798:0.004738:0.005819:0.011682:0.003421
.  Weight  loss interven-:@0.719707:0.528752:0.914551:0.528752:0.914551:0.514747:0.719707:0.514747:0.004738:0.004738:0.005821:0.015618:0.011118:0.003421:0.011511:0.010434:0.005798:0.004738:0.005817:0.003421:0.011203:0.006636:0.006636:0.010570:0.003421:0.010434:0.005798:0.011118:0.005148:0.009476:0.011118:0.010434:0.005679
tion trials in women with breast cancer::@0.560000:0.542334:0.914556:0.542334:0.914556:0.528329:0.560000:0.528329:0.005798:0.003421:0.011203:0.010434:0.009938:0.005798:0.005148:0.003421:0.011682:0.003421:0.006636:0.009938:0.003421:0.010434:0.009938:0.014214:0.011203:0.016044:0.011118:0.010434:0.009938:0.014214:0.003421:0.005798:0.010434:0.009938:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.009938:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
a systematic review. :@0.560000:0.555916:0.754217:0.555916:0.754217:0.541911:0.560000:0.541911:0.011682:0.015633:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.015633:0.005077:0.011118:0.009476:0.003421:0.011118:0.014214:0.004738:0.004738
Obesity  Reviews.:@0.765112:0.555916:0.914533:0.555916:0.914533:0.541911:0.765112:0.541911:0.014864:0.011665:0.011118:0.006636:0.003421:0.005798:0.009168:0.004738:0.010909:0.010382:0.011118:0.009476:0.003421:0.011118:0.014214:0.006636:0.004738
2014;5(9):749-768.:@0.560000:0.569498:0.706225:0.569498:0.706225:0.555493:0.560000:0.555493:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
17.   Chao  P, :@0.523653:0.583080:0.637324:0.583080:0.637324:0.569075:0.523653:0.569075:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.010434:0.011682:0.011203:0.004738:0.007866:0.008019:0.004738:-0.005786
et al:@0.645197:0.583080:0.689822:0.583080:0.689822:0.569075:0.645197:0.569075:0.011118:0.005798:0.012606:0.011682:0.003421
. The Malnutrition Univer-:@0.689822:0.583080:0.914574:0.583080:0.914574:0.569075:0.689822:0.569075:0.004738:0.012606:0.007286:0.010434:0.011118:0.012606:0.015719:0.011682:0.003421:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.012606:0.011203:0.010434:0.003421:0.009476:0.011118:0.005148:0.005679
sal Screening  Tool  (MUST)  and  a  nutrition:@0.560000:0.596662:0.914575:0.596662:0.914575:0.582657:0.560000:0.582657:0.006636:0.011682:0.003421:0.008501:0.008518:0.011067:0.005078:0.011118:0.011118:0.010434:0.003421:0.010434:0.011511:0.004738:0.003744:0.006448:0.011203:0.011203:0.003421:0.004738:0.003749:0.006312:0.015719:0.011203:0.008518:0.007286:0.006312:0.004738:0.003749:0.011682:0.010434:0.011716:0.004738:0.003753:0.011682:0.004738:0.003754:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434
education  program  for  high  risk cancer:@0.560000:0.610244:0.914574:0.610244:0.914574:0.596239:0.560000:0.596239:0.011118:0.011716:0.010399:0.011067:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.005975:0.011665:0.005080:0.011203:0.011511:0.005148:0.011682:0.016044:0.004738:0.005971:0.005371:0.011203:0.005148:0.004738:0.005973:0.010434:0.003421:0.011511:0.010434:0.004738:0.005976:0.005148:0.003421:0.006636:0.008586:0.010724:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148
patients: strategies to  improve dietary in-:@0.560000:0.623826:0.914568:0.623826:0.914568:0.609820:0.560000:0.609820:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.008364:0.006636:0.005798:0.005148:0.011682:0.005798:0.011118:0.011511:0.003421:0.011118:0.006636:0.008364:0.005798:0.011203:0.004738:0.003618:0.003421:0.016044:0.011665:0.005083:0.011203:0.009476:0.011118:0.008364:0.011716:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168:0.008364:0.003421:0.010434:0.005679
take  in cancer  patients. :@0.560000:0.637408:0.786301:0.637408:0.786301:0.623402:0.560000:0.623402:0.005798:0.011682:0.008586:0.011118:0.004738:0.008166:0.003421:0.010434:0.012914:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.008162:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738
Bio Medicine:@0.794467:0.637408:0.909836:0.637408:0.909836:0.623402:0.794467:0.623402:0.009818:0.003421:0.011203:0.012914:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118
.:@0.909836:0.637408:0.914574:0.637408:0.914574:0.623402:0.909836:0.623402:0.004738
2015;5(3):30-35.:@0.560000:0.650990:0.687274:0.650990:0.687274:0.636984:0.560000:0.636984:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
18.  Stanton  AL,  Rowland JH, Ganz Pa. Life:@0.523653:0.664572:0.914580:0.664572:0.914580:0.650566:0.523653:0.650566:0.009476:0.009476:0.004738:0.012657:0.000000:0.008518:0.005798:0.011682:0.010434:0.005798:0.011203:0.010434:0.004738:0.006756:0.012657:0.007902:0.004738:0.004738:0.006763:0.010382:0.011203:0.014214:0.003421:0.011682:0.010434:0.011716:0.011511:0.008244:0.011682:0.004738:0.011511:0.014915:0.011682:0.010434:0.007269:0.011511:0.010126:0.011682:0.004738:0.011511:0.007902:0.003421:0.005371:-0.395196
after  diagnosis and  treatment  of  can-:@0.560000:0.678154:0.914565:0.678154:0.914565:0.664148:0.560000:0.664148:0.011682:0.005371:0.005798:0.011118:0.005148:0.004738:0.008588:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.013341:0.011682:0.010434:0.011716:0.004738:0.008595:0.005798:0.005077:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005798:0.004738:0.008585:0.011203:0.005371:0.004738:0.008590:0.011067:0.011682:0.010434:0.005679
cer in adulthood. :@0.560000:0.691735:0.715299:0.691735:0.715299:0.677730:0.560000:0.677730:0.011067:0.011118:0.005148:0.008535:0.003421:0.010434:0.008535:0.011682:0.011716:0.010399:0.003421:0.005798:0.010434:0.011203:0.011203:0.011708:0.004738:0.004738
American Psychologist.:@0.719096:0.691735:0.914565:0.691735:0.914565:0.677730:0.719096:0.677730:0.012657:0.016044:0.011118:0.005148:0.003421:0.011067:0.011682:0.010434:0.008535:0.010126:0.006636:0.009168:0.011067:0.010434:0.011203:0.003421:0.011203:0.011511:0.003421:0.006636:0.005798:0.004738
2015;70(2):159-174.:@0.560000:0.705317:0.715701:0.705317:0.715701:0.691312:0.560000:0.691312:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
19.  Van  Blarigan  EL,  Meyerhardt  JA.  Role:@0.523653:0.718605:0.914556:0.718605:0.914556:0.704600:0.523653:0.704600:0.009476:0.009476:0.004738:0.012657:0.000000:0.010228:0.011682:0.010434:0.004738:0.010083:0.009818:0.003421:0.011682:0.005148:0.003421:0.011511:0.011682:0.010434:0.004738:0.010081:0.009168:0.007902:0.004738:0.004738:0.010081:0.015719:0.011118:0.009168:0.011118:0.005634:0.010434:0.011682:0.005044:0.011716:0.005798:0.004738:0.010081:0.008244:0.012657:0.004738:0.004738:0.010074:0.010382:0.011203:0.003421:-0.473766
of  physical activity and diet after  colo-:@0.560000:0.731893:0.914568:0.731893:0.914568:0.717888:0.560000:0.717888:0.011203:0.005371:0.004738:0.005771:0.011665:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421:0.010519:0.011682:0.011067:0.005798:0.003421:0.009476:0.003421:0.005798:0.009168:0.010519:0.011682:0.010434:0.011716:0.010519:0.011716:0.003421:0.011118:0.005798:0.010519:0.011682:0.005371:0.005798:0.011118:0.005148:0.004738:0.005769:0.011067:0.011203:0.003421:0.011203:0.005679
rectal cancer  diagnosis. :@0.560000:0.745181:0.782548:0.745181:0.782548:0.731176:0.560000:0.731176:0.005078:0.011118:0.011067:0.005798:0.011682:0.003421:0.013872:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.009122:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.004738:0.004738
J Clin Oncol.:@0.791682:0.745181:0.914577:0.745181:0.914577:0.731176:0.791682:0.731176:0.008244:0.013872:0.013906:0.003421:0.003421:0.010434:0.013872:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
2015;33(16):1825-1834.:@0.560000:0.758469:0.744129:0.758469:0.744129:0.744464:0.560000:0.744464:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
20.   Wright SJ, :@0.523653:0.771757:0.642228:0.771757:0.642228:0.757752:0.523653:0.757752:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015926:0.005148:0.003421:0.011511:0.010434:0.005798:0.003751:0.008518:0.008244:0.004738:-0.285129
et al:@0.641246:0.771757:0.677020:0.771757:0.677020:0.757752:0.641246:0.757752:0.011118:0.005798:0.003754:0.011682:0.003421
. What are colorectal cancer :@0.677020:0.771757:0.919325:0.771757:0.919325:0.757752:0.677020:0.757752:0.004738:0.003763:0.016420:0.010434:0.011682:0.005798:0.003754:0.011682:0.005078:0.011118:0.003763:0.011067:0.011203:0.003421:0.011203:0.005078:0.011118:0.011067:0.005798:0.011682:0.003421:0.003763:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
survivors preferences for  dietary advice?:@0.560000:0.785045:0.914558:0.785045:0.914558:0.771040:0.560000:0.771040:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.009715:0.011665:0.005080:0.011118:0.005371:0.011118:0.005073:0.011118:0.010434:0.011067:0.011118:0.006636:0.009715:0.005371:0.011203:0.005148:0.004738:0.004969:0.011716:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168:0.009715:0.011682:0.011716:0.009476:0.003421:0.011067:0.011118:0.010109
A best-worst  discrete choice experiment.:@0.560000:0.798627:0.914580:0.798627:0.914580:0.784622:0.560000:0.784622:0.012657:0.008740:0.011665:0.011118:0.006636:0.005798:0.005679:0.014214:0.011203:0.005148:0.006636:0.005798:0.004738:0.003994:0.011716:0.003421:0.006636:0.011067:0.005078:0.011118:0.005798:0.011118:0.008740:0.011067:0.010434:0.011203:0.003421:0.011067:0.011118:0.008740:0.011118:0.008210:0.011665:0.011118:0.005148:0.003421:0.016044:0.011118:0.010434:0.005798:0.004738
J Cancer Surviv:@0.560000:0.812209:0.687513:0.812209:0.687513:0.798204:0.560000:0.798204:0.008244:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.008518:0.010399:0.005148:0.009476:0.003421:0.009476
. 2017;11:782-790.:@0.687513:0.812209:0.830591:0.812209:0.830591:0.798204:0.687513:0.798204:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
21.   Zhang B, :@0.523653:0.825791:0.638371:0.825791:0.638371:0.811786:0.523653:0.811786:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008210:0.010434:0.011682:0.010434:0.011511:0.006806:0.009818:0.004738:-0.359867
et al:@0.640442:0.825791:0.679269:0.825791:0.679269:0.811786:0.640442:0.811786:0.011118:0.005798:0.006808:0.011682:0.003421
. Association of whole grain:@0.679269:0.825791:0.914556:0.825791:0.914556:0.811786:0.679269:0.811786:0.004738:0.006808:0.012657:0.006636:0.006636:0.011203:0.011067:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.006808:0.011203:0.005371:0.006808:0.014214:0.010434:0.011203:0.003421:0.011118:0.006808:0.011511:0.005148:0.011682:0.003421:0.010434
intake  with  all-cause,  cardiovascular,  and:@0.560000:0.839373:0.914553:0.839373:0.914553:0.825368:0.560000:0.825368:0.003421:0.010434:0.005798:0.011682:0.008586:0.011118:0.004738:0.002605:0.014214:0.003421:0.005798:0.010434:0.004738:0.002607:0.011682:0.003421:0.003421:0.005679:0.011067:0.011693:0.010399:0.006636:0.011118:0.004738:0.004738:0.002603:0.011067:0.011682:0.005046:0.011716:0.003421:0.011203:0.009476:0.011682:0.006636:0.011067:0.010399:0.003421:0.011682:0.003352:0.004738:0.004738:0.002605:0.011682:0.010434:0.011716
cancer mortality: a systematic review and:@0.560000:0.853543:0.914582:0.853543:0.914582:0.839538:0.560000:0.839538:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.006057:0.016044:0.011203:0.005148:0.005798:0.011682:0.003421:0.003421:0.005798:0.009168:0.004738:0.006063:0.011682:0.006072:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.006072:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.006072:0.011682:0.010434:0.011716
dose-response  meta-analysis from  pro-:@0.560000:0.867713:0.914560:0.867713:0.914560:0.853707:0.560000:0.853707:0.011716:0.011203:0.006636:0.011118:0.005679:0.005077:0.011118:0.006636:0.011665:0.011203:0.010434:0.006636:0.011118:0.004738:0.011792:0.016044:0.011118:0.005798:0.011682:0.005679:0.011682:0.010434:0.011682:0.003421:0.009168:0.006636:0.003421:0.006636:0.016540:0.005371:0.005077:0.011203:0.016044:0.004738:0.011788:0.011665:0.005080:0.011203:0.005679
spective cohort  studies. :@0.560000:0.881883:0.772368:0.881883:0.772368:0.867877:0.560000:0.867877:0.006636:0.011665:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.011015:0.011067:0.011203:0.010434:0.011203:0.005148:0.005798:0.004738:0.006260:0.006636:0.005798:0.010399:0.011716:0.003421:0.011118:0.006636:0.004738:0.004738
Eur J Clin Nutr.:@0.778645:0.881883:0.914574:0.881883:0.914574:0.867877:0.778645:0.867877:0.009168:0.010399:0.005148:0.011015:0.008244:0.011015:0.013906:0.003421:0.003421:0.010434:0.011015:0.012657:0.010399:0.005798:0.005148:0.004738
2018;72:57-65.:@0.560000:0.896053:0.674651:0.896053:0.674651:0.882047:0.560000:0.882047:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738